The role of the Histology Laboratory Core is to coordinate and provide professional and technical services for proper handling and processing of histopathologic materials.
Specific aims are as follows: 1) to prepare routine hematoxylin and eosin (H & E)-stained pathology slides for histopathologic examination of the bronchial biopsy samples, and 2) to prepare and distribute tissue sections required for special histopathologic examinations and in-situ hybridization studies. The main purpose of this project is to develop effective chemopreventive approaches in former smokers and to identify potentially useful biomarkers of intermediate endpoints. We expect to deal with a large bulk of histopathologic materials in this project. In addition, some studies require special care in preparing the tissue sections. For example, in- situ mRNA hybridization studies (e.g., retinoic acid rector gene expression), the slides should be prepared using a specially treated water to avoid RNA degradation, which can not be accommodated by the regular pathology department personnel. Therefore, it is essential to establish a separate core facility for successful control of this project. As the clinical trial progresses to attain the targeted sample size, more Core effort will be required in the preparation and distribution of tissue sections for the translational research projects. The role of this Core will become increasingly important because proposed studies and further progress in the field of carcinogenesis research may identify new cellular, biochemical, or molecular genetic markers of interest. These will need to be tested and expanded using the tissue samples obtained through this project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
3U19CA068437-04S1
Application #
6103133
Study Section
Project Start
1998-08-01
Project End
1999-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Tam, Alda L; Kim, Edward S; Lee, J Jack et al. (2013) Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial. J Thorac Oncol 8:436-42
Hittelman, Walter N; Liu, Diane D; Kurie, Jonathan M et al. (2007) Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. J Natl Cancer Inst 99:1603-12
Gu, Jian; Wu, Xifeng; Dong, Qiong et al. (2006) A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans. Cancer 106:2716-24
Han, Ji-Youn; Liu, Diane D; Lee, J Jack et al. (2005) 9-cis-retinoic acid treatment increases serum concentrations of alpha-tocopherol in former smokers. Clin Cancer Res 11:2305-11
Lee, Ho-Young; Chang, Yoon Soo; Han, Ji-Youn et al. (2005) Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. J Clin Oncol 23:4439-49
Wu, Xifeng; Roth, Jack A; Zhao, Hua et al. (2005) Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res 65:349-57
Tang, Ximing; Wu, Weiguo; Sun, Shi-Yong et al. (2004) Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells. Mol Cancer Res 2:685-91
Lu, Tao; Hittelman, Walter N (2004) Improvement and application of fluorescence inter-simple sequence repeat polymerase chain reaction for the study of subclonal growths in lung epithelial cell populations. Chest 125:110S-1S
Wu, Xifeng; Schabath, Matthew B; Spitz, Margaret R (2003) Myeloperoxidase promoter region polymorphism and lung cancer risk. Methods Mol Med 75:121-33
Chang, Yoon Soo; Wu, Weiguo; Walsh, Garrett et al. (2003) Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clin Cancer Res 9:3641-4

Showing the most recent 10 out of 80 publications